CD274, Human (Durvalumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-CD274, Human (Durvalumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD274, Human (Durvalumab biosimilar) |
| Clone | Durvalumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | ELISA, IHC, FCM, IP, IF, Inhib, FuncS |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human CD274 Recombinant Antibody (Durvalumab). Durvalumab (trade name Imfinzi) is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1 ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 (CD279). Durvalumab is known as a checkpoint inhibitor drug. |
| Immunogen | n/a |
| Other Names | Anti-CD274 Recombinant Antibody, Research Grade Durvalumab, Anti-Human CD274 Recombinant Antibody(Durvalumab), MEDI4736, Antibody Drug Analogues, Monoclonal Antibody, YR1356, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1428935-60-7 |
| Catalog # | YR1356 |
| Price | please inquire |
| Order / More Info | CD274, Human (Durvalumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies